etanercept products — Cigna

Initial criteria

• Patient age > 6 years; AND patient has tried at least one systemic treatment for graft-versus-host disease (e.g., systemic corticosteroids, antithymocyte globulin, cyclosporine, tacrolimus, mycophenolate mofetil, imatinib, methotrexate, belumosudil, axatilimab, hydroxychloroquine, rituximab, ruxolitinib, ibrutinib, basiliximab, infliximab, sirolimus, pentostatin, etc.)

Approval duration

initial 1 month